Document is current
Any future updates will be listed below
-
Authors
Olwi, Duaa I. https://orcid.org/0000-0003-3581-8390
Kaisinger, Lena R. https://orcid.org/0000-0002-0849-3191
Kentistou, Katherine A. https://orcid.org/0000-0002-5816-664X
Vaudel, Marc
Stankovic, Stasa https://orcid.org/0000-0002-6602-1379
Njølstad, Pål R. https://orcid.org/0000-0003-0304-6728
Johansson, Stefan
Perry, John R. B. https://orcid.org/0000-0001-6483-3771
Day, Felix R. https://orcid.org/0000-0003-3789-7651
Ong, Ken K. https://orcid.org/0000-0003-4689-7530
- License Information
-
More Information
Article History
Received: 8 September 2023
Revised: 23 July 2024
Accepted: 6 August 2024
First Online: 22 August 2024
Competing interests
: JRBP is an employee of and holds shares in Insmed Inc.
: The establishment of MoBa and initial data collection was based on a licence from the Norwegian Data Protection Agency and approval from The Regional Committees for Medical and Health Research Ethics. The MoBa cohort is currently regulated by the Norwegian Health Registry Act. The current study was approved by The Regional Committees for Medical and Health Research Ethics (no. 2012/67). UK Biobank received ethical approval from the NHS National Research Ethics Service NorthWest (11/NW/0382).
